Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
E J Goldstein

Abstract

The currently available fluoroquinolones have modest activity against anaerobes. Newer fluoroquinolones with increased in vitro activity against anaerobes are under development and include levofloxacin, clinafloxacin, sparfloxacin, trovafloxacin, grepafloxacin, and DU-6859a. Side effects of the quinolones have varied according to the specific compounds and include central nervous system stimulation, gastrointestinal disturbances, vasculitis, and photosensitization. Monitoring for toxicity is incompletely reliable in identifying all potential serious side effects such as the "temafloxacin syndrome." Other fluoroquinolones may produce this syndrome rarely or not at all. In this paper, I review limited published studies on the use of these agents for skin and skin-structure infections and gynecologic infections. Studies in progress are noted, and when available, in vitro data on the efficacy of these agents against bacterial isolates from specific sources are reviewed and evaluated in terms of potential clinical utility.

Citations

Nov 30, 2000·Current Infectious Disease Reports·G Chung, M B Goetz
Jul 19, 2001·Bioorganic & Medicinal Chemistry Letters·A ThorarensenB H Yagi
Dec 26, 2001·Antimicrobial Agents and Chemotherapy·M L PetersonJ C Rotschafer
Jan 3, 2012·Veterinary Microbiology·Peter SilleyAndrew Pridmore
Jul 6, 2004·International Journal of Pharmaceutics·M BudaiP Gróf
Jul 10, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H Oh, C Edlund
Aug 5, 2000·The Annals of Pharmacotherapy·A A Alghasham, M C Nahata
Sep 18, 2007·The Journal of Antimicrobial Chemotherapy·Peter SilleyAndrew Pridmore
Oct 20, 2001·Pharmacotherapy·D N Fish
Feb 22, 2003·Surgical Infections·R L Nichols
May 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gary E Stein, Ellie J C Goldstein
May 5, 2000·The Cochrane Database of Systematic Reviews·E Sailas, M Fenton
Aug 13, 2011·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Angelena Maria LabellaElizabeth Anne Phelan
Sep 28, 2001·The Annals of Pharmacotherapy·J A Paladino
Nov 14, 2013·Experimental and Therapeutic Medicine·J Y R WongH M Er
Sep 3, 1999·Antimicrobial Agents and Chemotherapy·M L PetersonJ C Rotschafer
Oct 3, 1999·Antimicrobial Agents and Chemotherapy·S L PendlandL H Danziger
Jun 1, 2000·Infectious Disease Clinics of North America·J A O'Donnell, S P Gelone
Nov 2, 2014·Journal of Chemical Information and Modeling·Yan WangDavid Chi-Cheong Wan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
B A Lipsky, C A Baker
Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie
B A Finegan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
S Nachnani, G T Clark
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
S M Finegold
© 2021 Meta ULC. All rights reserved